Off-Label Promotion: DOJ May Take New Look At Scientific Information Exchange

 
• By Sarah Karlin-Smith
  
Paper with "Scientific Discoveries" and news and information printed at the top.
The exchange of scientific information on off-label uses may be drawing unexpected attention from the Trump DOJ. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Litigation

More from US FDA